StockNews.com Initiates Coverage on DURECT (NASDAQ:DRRX)

Equities research analysts at StockNews.com began coverage on shares of DURECT (NASDAQ:DRRX – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a “neutral” rating on shares of DURECT in a research note on Thursday, November 14th. […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Begins Coverage on Trio-Tech International (NYSE:TRT)
Next post Battenfeld: Michelle Obama latest Democrat to pass on Donald Trump’s Inauguration